Aurora Cannabis Inc. (TSX:ACB): Riskier Than Bitcoin?

Investors would rather stay from Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) in the same way they avoid Bitcoin. The weed stock is not the best choice because the company is presently in a precarious state.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

The hype in the cannabis sector picked up from where the excitement in the most popular cryptocurrency ended. Both the cryptos and cannabis created bandwagon effects. Bitcoin’s glow as an emerging investment opportunity faded. Will the pre-ordained largest cannabis producer suffer the same fate?

Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) can be the representative of cannabis in the same breath as Bitcoin is in the cryptocurrency world. That could happen in the event the company’s annual production jumps by 36.84% from 570,000 kilograms to 780,000 kilograms not later than 2022.

The bitcoin craze

Bitcoin produced many millionaires, but also caused the insolvency of many newbie investors. Investor interest in Bitcoin and other digital currencies soared to abnormal levels. The rise of bitcoin was utterly fantastic. From US$1,000 in early 2017, the price climbed close to US$20,000 or 1,900% by mid-December.

Value investor and billionaire Warren Buffett warned that bitcoin has “no unique value at all” and is basically a delusion. However, Buffett believes the underlying technology or ‘blockchain technology’ is valuable but cryptocurrency will not be instrumental to its success.

As of this writing, a bitcoin is worth US$5,431.95, or about -73% lower than $20,000. Those who came in late and invested US$1,000 at the peak, the value of their bitcoins are less than US$300. But don’t count out bitcoin yet. Proponents are certain that cryptocurrencies will soon be true-blue investments like stocks.

The cannabis mania

Unlike bitcoin and the cryptocurrency market in general, the cannabis sector’s legitimacy is not suspect. Aurora Cannabis is listed on both the New York Stock Exchange and the Toronto Stock Exchange. The shares of the company are traded alongside iconic American and Canadian corporations.

Aurora Cannabis is somehow viewed as a risky investment because of its own doing. However, the stock price will surely not fall by 1,900%. The honeymoon period is over and investors are waiting for Aurora Cannabis to be on the path to profitability.

Not the best choice

Aurora Cannabis is an industry giant, but is still finding its way. The company is under scrutiny because it’s doing things inimical to prospective investors and shareholders. Most cannabis players are not without debt. But Aurora Cannabis’ debt obligations are frightening.

Aurora Cannabis is raising funds via the issuance of convertible debt. While the funds would be utilized for expansion, current shareholders will be diluted and share value will drop. Industry peers are not in a precarious state, as they are partnered with institutional investors with the funding muscles.

While the cannabis sector is in a wild and woolly state at present, Aurora Cannabis has a higher degree of risk compared with the rest. The company is too preoccupied with growth that profitability and shareholder value have been relegated to the background.

Similar to bitcoin, Aurora Cannabis is a risky play. Given the current circumstance, it’s not the best choice, not yet. Other weed stocks are doing better in terms of ensuring growth and protecting shareholder value.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »